Skip to main content
Figure 3 | AIDS Research and Therapy

Figure 3

From: Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia

Figure 3

Mean CD4+ count increase (cells/μl) with 95% Confidence interval (95% CI) over time after the start of HAART. CD4+ T cell count was measured at ART start, six month (M6), M18, and M24 of HAART in HIV patients with TB (HIV + TB+) (continuous line), with no TB (HIV + TB-) (dotted line), and HIV patients with TB and HBV (HIV + TB + HBV) (dash line) (A), and HIV + TB- patients sub-grouped as those with TST positive (HIV + TST+) (continuous line) and those TST negative (HIV + TST-) (dash line) (B). Number of CD4+ T cell counts per follow-up visit are shown on the line graphs; n = number of participants per visit.

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us